A curriculum guide to support educators in ensuring that pharmacists are better able to prevent substandard or falsified (SF) medicines and medical products from reaching patients has been published by the International Pharmaceutical Federation (FIP) in partnership with the World Health Organization (WHO). In 2017, the WHO estimated that one in 10 medicines in low- and middle-income countries was SF, risking harm to people and reducing the quality of patient care.
The curriculum guide is a tool for education on SF medical products, which can be adapted to the needs of individual training institutions. It contains a competency framework and practical tips and is supplemented with modules that align with the WHO prevention-detection-response strategy so that pharmacists know how to: identify medicines at high-risk of being SF; prevent these products reaching the supply chain and, if they have, detect them and report them to appropriate regulatory authorities; and intervene to prevent patient harm.
Read the Guide here.